Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gingival response to nicotine polacrilex.

K J Silver1, D P Sachs, T L Hottel

  • 1Division of Respiratory Therapy, Stanford University, School of Medicine, CA.

Journal of the American Dental Association (1939)
|January 1, 1989
PubMed
Summary

Nicotine polacrilex (Nicorette) is an FDA-approved prescription medication for tobacco dependence. This study found it does not cause significant adverse gingival effects, with minor, transient vesicles being the only noted issue.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salmonella in Commercially Produced Dried Dog Food: Possible Relationship to a Human Infection Caused by Salmonella enteritidis Serotype Havana.

Journal of food protection·2019
Same author

A comprehensive clinical competency-based assessment in periodontics.

European journal of dental education : official journal of the Association for Dental Education in Europe·2016
Same author

Neighborhood socio-economic context and emergency department visits for dental care in a U.S. Midwestern metropolis.

Public health·2015
Same author

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

Annals of internal medicine·2001
Same author

The "flexible augmented flange technique" for fabricating complete denture record bases.

Quintessence international (Berlin, Germany : 1985)·2001
Same author

Cigarette smoking, pulmonary metastases, and breast carcinoma: coincidence or causality?

Chest·2001

Area of Science:

  • Oral Health
  • Pharmacology
  • Addiction Medicine

Background:

  • Nicotine polacrilex is the sole FDA-approved prescription medication for tobacco dependency.
  • Concerns exist regarding potential adverse effects of nicotine polacrilex on gingival tissues.

Purpose of the Study:

  • To investigate the potential adverse gingival effects associated with nicotine polacrilex use.
  • To evaluate the safety profile of nicotine polacrilex concerning oral tissues.

Main Methods:

  • Thirty-one patients using nicotine polacrilex for at least one month were assessed.
  • Gingival health parameters including color, contour, consistency, texture, mobility, and pocket depth were monitored.
  • Incidence of any adverse oral events was recorded.

Related Experiment Videos

Main Results:

  • Five patients (15%) developed small, painless vesicles that resolved upon repositioning the medication.
  • No significant changes were observed in gingival color, contour, consistency, texture, tooth mobility, or periodontal pocket depth.
  • No significant adverse effects on the gingiva were noted even with up to six months of daily use.

Conclusions:

  • Nicotine polacrilex does not appear to cause significant adverse gingival effects.
  • The medication is generally well-tolerated by gingival tissues.
  • Minor, transient vesicles are the primary observed side effect, manageable with proper usage instructions.